OraSure Technologies, Inc.Bethlehem, PA United States
Company Description
When it comes to diagnostic tests, OraSure is certain it can deliver results. The oral specimen kits and other diagnostic tests developed by OraSure Technologies are designed to detect drug use and certain infectious diseases, namely HIV. The company's OraSure products use oral specimens rather than traditional blood or urine based methods to test for HIV. Its Intercept line uses oral samples to test for marijuana, cocaine, opiates, PCP, and amphetamines. OraSure has also developed a rapid HIV blood diagnostic testing method. The company sells its products in the US and internationally through direct agents and independent distributors, primarily to public health clinics, hospitals, and doctors' offices.
| 220 E. 1st St. | Phone: 610-882-1820 | http://www.orasure.com |
| Bethlehem, PA 18015 | Fax: 610-882-1830 | |
| United States |
OraSure Technologies, Inc. Rankings
| Russell 2000 (June 2011) |
Executives
| 34 executives listed for OraSure Technologies, Inc.'s Bethlehem, PA location. | ||
| Chairman | Douglas Watson | |
|---|---|---|
| President, CEO, and Director | Douglas Michels | |
| CFO, COO, and Director | RonaldSpair | |
Financials
| Company Type | Public - NASDAQ: OSUR Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 308 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on OraSure Technologies, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
